Next generation peptide drugs favor synthetic, not recombinant manufacturing
The recent introduction of new drugs in the areas of diabetes, obesity, and cardiovascular disease have greatly increased the demand for manufacturing of polypeptides In turn, rapidly increasing commercialization of peptide drugs has driven an industrial...